| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 7.11e-05 | 46 | 35 | 3 | GO:0030020 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.17e-04 | 188 | 35 | 4 | GO:0005201 | |
| GeneOntologyCellularComponent | collagen trimer | 1.09e-05 | 88 | 33 | 4 | GO:0005581 | |
| Domain | Collagen | 1.30e-05 | 85 | 32 | 4 | PF01391 | |
| Domain | Collagen | 1.30e-05 | 85 | 32 | 4 | IPR008160 | |
| Domain | Bromodomain_CS | 9.01e-04 | 26 | 32 | 2 | IPR018359 | |
| Domain | C1Q | 1.37e-03 | 32 | 32 | 2 | SM00110 | |
| Domain | C1q | 1.37e-03 | 32 | 32 | 2 | PF00386 | |
| Domain | C1q_dom | 1.54e-03 | 34 | 32 | 2 | IPR001073 | |
| Domain | C1Q | 1.54e-03 | 34 | 32 | 2 | PS50871 | |
| Domain | BROMODOMAIN_1 | 1.82e-03 | 37 | 32 | 2 | PS00633 | |
| Domain | Bromodomain | 1.92e-03 | 38 | 32 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 2.24e-03 | 41 | 32 | 2 | PS50014 | |
| Domain | BROMO | 2.35e-03 | 42 | 32 | 2 | SM00297 | |
| Domain | Bromodomain | 2.35e-03 | 42 | 32 | 2 | IPR001487 | |
| Domain | - | 2.35e-03 | 42 | 32 | 2 | 1.20.920.10 | |
| Domain | - | 3.31e-03 | 50 | 32 | 2 | 2.60.120.40 | |
| Domain | Tumour_necrosis_fac-like_dom | 4.43e-03 | 58 | 32 | 2 | IPR008983 | |
| Pubmed | 1.16e-06 | 170 | 38 | 5 | 15057823 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 26418130 | ||
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 5.20e-05 | 10 | 38 | 2 | 15345741 | |
| Pubmed | 6.35e-05 | 11 | 38 | 2 | 21782286 | ||
| Pubmed | 6.35e-05 | 11 | 38 | 2 | 27067865 | ||
| Pubmed | FOXD1 is required for 3D patterning of the kidney interstitial matrix. | 9.00e-05 | 13 | 38 | 2 | 36335435 | |
| Pubmed | SMARCA4 Loss and Mutated β-Catenin Induce Proliferative Lesions in the Murine Embryonic Cerebellum. | 1.05e-04 | 14 | 38 | 2 | 38383496 | |
| Pubmed | Directional neuronal migration is impaired in mice lacking adenomatous polyposis coli 2. | 1.21e-04 | 15 | 38 | 2 | 22573669 | |
| Pubmed | 1.38e-04 | 16 | 38 | 2 | 24142690 | ||
| Pubmed | 1.76e-04 | 18 | 38 | 2 | 27392482 | ||
| Pubmed | 1.96e-04 | 19 | 38 | 2 | 29196262 | ||
| Pubmed | 2.18e-04 | 20 | 38 | 2 | 25535916 | ||
| Pubmed | 2.18e-04 | 20 | 38 | 2 | 34220450 | ||
| Pubmed | Brg1 is required for murine neural stem cell maintenance and gliogenesis. | 3.16e-04 | 24 | 38 | 2 | 16330018 | |
| Pubmed | 3.72e-04 | 26 | 38 | 2 | 17875933 | ||
| Pubmed | 4.01e-04 | 27 | 38 | 2 | 26628093 | ||
| Pubmed | 4.32e-04 | 28 | 38 | 2 | 35666215 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 4.37e-04 | 135 | 38 | 3 | 28675934 | |
| Pubmed | 4.63e-04 | 29 | 38 | 2 | 26959361 | ||
| Pubmed | 6.91e-04 | 653 | 38 | 5 | 22586326 | ||
| Pubmed | Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach. | 7.97e-04 | 38 | 38 | 2 | 16263699 | |
| Pubmed | 8.11e-04 | 167 | 38 | 3 | 22159717 | ||
| Pubmed | 9.28e-04 | 175 | 38 | 3 | 28071719 | ||
| Interaction | ZNF683 interactions | 4.54e-12 | 10 | 38 | 5 | int:ZNF683 | |
| Interaction | CELF4 interactions | 8.31e-12 | 11 | 38 | 5 | int:CELF4 | |
| Interaction | BEND2 interactions | 1.42e-11 | 12 | 38 | 5 | int:BEND2 | |
| Interaction | PTTG2 interactions | 3.58e-11 | 14 | 38 | 5 | int:PTTG2 | |
| Interaction | MBNL3 interactions | 7.80e-11 | 16 | 38 | 5 | int:MBNL3 | |
| Interaction | BICRAL interactions | 1.72e-10 | 43 | 38 | 6 | int:BICRAL | |
| Interaction | PRR34 interactions | 3.61e-10 | 21 | 38 | 5 | int:PRR34 | |
| Interaction | TPRX1 interactions | 3.61e-10 | 21 | 38 | 5 | int:TPRX1 | |
| Interaction | C3orf36 interactions | 1.16e-09 | 26 | 38 | 5 | int:C3orf36 | |
| Interaction | ZNF385C interactions | 4.14e-09 | 33 | 38 | 5 | int:ZNF385C | |
| Interaction | HLX interactions | 7.56e-09 | 37 | 38 | 5 | int:HLX | |
| Interaction | ZCCHC14 interactions | 7.56e-09 | 37 | 38 | 5 | int:ZCCHC14 | |
| Interaction | TBX6 interactions | 1.29e-08 | 41 | 38 | 5 | int:TBX6 | |
| Interaction | FAM222B interactions | 1.47e-08 | 42 | 38 | 5 | int:FAM222B | |
| Interaction | SAMD11 interactions | 1.66e-08 | 43 | 38 | 5 | int:SAMD11 | |
| Interaction | SP4 interactions | 2.35e-08 | 46 | 38 | 5 | int:SP4 | |
| Interaction | KRTAP19-1 interactions | 2.63e-08 | 47 | 38 | 5 | int:KRTAP19-1 | |
| Interaction | OXER1 interactions | 3.61e-08 | 50 | 38 | 5 | int:OXER1 | |
| Interaction | RIPPLY1 interactions | 5.89e-08 | 55 | 38 | 5 | int:RIPPLY1 | |
| Interaction | ZBTB32 interactions | 7.73e-08 | 58 | 38 | 5 | int:ZBTB32 | |
| Interaction | FAM9A interactions | 8.43e-08 | 59 | 38 | 5 | int:FAM9A | |
| Interaction | CABP2 interactions | 9.99e-08 | 61 | 38 | 5 | int:CABP2 | |
| Interaction | C10orf55 interactions | 1.38e-07 | 65 | 38 | 5 | int:C10orf55 | |
| Interaction | SMAP1 interactions | 1.61e-07 | 67 | 38 | 5 | int:SMAP1 | |
| Interaction | TBX3 interactions | 1.87e-07 | 69 | 38 | 5 | int:TBX3 | |
| Interaction | ESRP1 interactions | 3.25e-07 | 77 | 38 | 5 | int:ESRP1 | |
| Interaction | RBPMS2 interactions | 4.73e-07 | 83 | 38 | 5 | int:RBPMS2 | |
| Interaction | PRR35 interactions | 4.73e-07 | 83 | 38 | 5 | int:PRR35 | |
| Interaction | DMRT3 interactions | 5.99e-07 | 87 | 38 | 5 | int:DMRT3 | |
| Interaction | PRR20B interactions | 7.09e-07 | 90 | 38 | 5 | int:PRR20B | |
| Interaction | PRR20C interactions | 7.09e-07 | 90 | 38 | 5 | int:PRR20C | |
| Interaction | PRR20D interactions | 7.09e-07 | 90 | 38 | 5 | int:PRR20D | |
| Interaction | RBM23 interactions | 8.81e-07 | 94 | 38 | 5 | int:RBM23 | |
| Interaction | KRTAP19-5 interactions | 1.14e-06 | 99 | 38 | 5 | int:KRTAP19-5 | |
| Interaction | PRR20E interactions | 1.26e-06 | 101 | 38 | 5 | int:PRR20E | |
| Interaction | TRIM35 interactions | 1.39e-06 | 103 | 38 | 5 | int:TRIM35 | |
| Interaction | C1orf94 interactions | 1.39e-06 | 103 | 38 | 5 | int:C1orf94 | |
| Interaction | RHOXF2 interactions | 1.46e-06 | 104 | 38 | 5 | int:RHOXF2 | |
| Interaction | GTF2A1 interactions | 1.46e-06 | 104 | 38 | 5 | int:GTF2A1 | |
| Interaction | VENTX interactions | 1.46e-06 | 104 | 38 | 5 | int:VENTX | |
| Interaction | VEZF1 interactions | 1.53e-06 | 105 | 38 | 5 | int:VEZF1 | |
| Interaction | GLIS2 interactions | 1.60e-06 | 106 | 38 | 5 | int:GLIS2 | |
| Interaction | SH3RF1 interactions | 1.76e-06 | 108 | 38 | 5 | int:SH3RF1 | |
| Interaction | FOXH1 interactions | 1.84e-06 | 109 | 38 | 5 | int:FOXH1 | |
| Interaction | PRR20A interactions | 1.84e-06 | 109 | 38 | 5 | int:PRR20A | |
| Interaction | NOTCH3 interactions | 2.20e-06 | 113 | 38 | 5 | int:NOTCH3 | |
| Interaction | BHLHE40 interactions | 2.83e-06 | 119 | 38 | 5 | int:BHLHE40 | |
| Interaction | THAP1 interactions | 2.83e-06 | 119 | 38 | 5 | int:THAP1 | |
| Interaction | HYPK interactions | 3.61e-06 | 125 | 38 | 5 | int:HYPK | |
| Interaction | PITX1 interactions | 3.90e-06 | 127 | 38 | 5 | int:PITX1 | |
| Interaction | CCNK interactions | 4.71e-06 | 132 | 38 | 5 | int:CCNK | |
| Interaction | YPEL3 interactions | 4.89e-06 | 133 | 38 | 5 | int:YPEL3 | |
| Interaction | VPS37C interactions | 6.51e-06 | 141 | 38 | 5 | int:VPS37C | |
| Interaction | FAM168A interactions | 6.74e-06 | 142 | 38 | 5 | int:FAM168A | |
| Interaction | ARID5A interactions | 7.97e-06 | 147 | 38 | 5 | int:ARID5A | |
| Interaction | POU6F2 interactions | 8.24e-06 | 148 | 38 | 5 | int:POU6F2 | |
| Interaction | PATZ1 interactions | 1.32e-05 | 163 | 38 | 5 | int:PATZ1 | |
| Interaction | ABI2 interactions | 1.46e-05 | 286 | 38 | 6 | int:ABI2 | |
| Interaction | PHF1 interactions | 1.71e-05 | 172 | 38 | 5 | int:PHF1 | |
| Interaction | TIAL1 interactions | 1.71e-05 | 172 | 38 | 5 | int:TIAL1 | |
| Interaction | POU2F1 interactions | 1.86e-05 | 175 | 38 | 5 | int:POU2F1 | |
| Interaction | NFYC interactions | 1.96e-05 | 177 | 38 | 5 | int:NFYC | |
| Interaction | HIVEP1 interactions | 2.49e-05 | 186 | 38 | 5 | int:HIVEP1 | |
| Interaction | DAZAP2 interactions | 2.49e-05 | 186 | 38 | 5 | int:DAZAP2 | |
| Interaction | ZC3H10 interactions | 3.52e-05 | 200 | 38 | 5 | int:ZC3H10 | |
| Interaction | VAC14 interactions | 3.61e-05 | 201 | 38 | 5 | int:VAC14 | |
| Interaction | RBPMS interactions | 3.86e-05 | 340 | 38 | 6 | int:RBPMS | |
| Interaction | ANKHD1 interactions | 5.08e-05 | 216 | 38 | 5 | int:ANKHD1 | |
| Interaction | SIAH1 interactions | 5.91e-05 | 223 | 38 | 5 | int:SIAH1 | |
| Interaction | LASP1 interactions | 9.58e-05 | 247 | 38 | 5 | int:LASP1 | |
| Interaction | TFG interactions | 1.18e-04 | 258 | 38 | 5 | int:TFG | |
| Interaction | NCK2 interactions | 1.26e-04 | 262 | 38 | 5 | int:NCK2 | |
| Interaction | POGZ interactions | 1.33e-04 | 265 | 38 | 5 | int:POGZ | |
| Interaction | FOXP3 interactions | 1.45e-04 | 432 | 38 | 6 | int:FOXP3 | |
| Interaction | BANP interactions | 1.64e-04 | 277 | 38 | 5 | int:BANP | |
| Interaction | DVL3 interactions | 1.72e-04 | 280 | 38 | 5 | int:DVL3 | |
| Interaction | TCF7L2 interactions | 1.87e-04 | 285 | 38 | 5 | int:TCF7L2 | |
| Interaction | TLX3 interactions | 2.06e-04 | 291 | 38 | 5 | int:TLX3 | |
| Interaction | MAGED1 interactions | 2.19e-04 | 295 | 38 | 5 | int:MAGED1 | |
| Interaction | EIF4ENIF1 interactions | 2.37e-04 | 300 | 38 | 5 | int:EIF4ENIF1 | |
| Interaction | RBM42 interactions | 3.73e-04 | 331 | 38 | 5 | int:RBM42 | |
| Interaction | ROR2 interactions | 3.83e-04 | 333 | 38 | 5 | int:ROR2 | |
| Interaction | FAM81B interactions | 4.62e-04 | 17 | 38 | 2 | int:FAM81B | |
| Interaction | TOLLIP interactions | 5.33e-04 | 358 | 38 | 5 | int:TOLLIP | |
| Interaction | DUSP16 interactions | 1.01e-03 | 237 | 38 | 4 | int:DUSP16 | |
| Interaction | CDC37 interactions | 1.21e-03 | 645 | 38 | 6 | int:CDC37 | |
| Interaction | NTAQ1 interactions | 1.23e-03 | 431 | 38 | 5 | int:NTAQ1 | |
| Interaction | SNRPC interactions | 1.34e-03 | 440 | 38 | 5 | int:SNRPC | |
| Interaction | FAM230I interactions | 1.36e-03 | 29 | 38 | 2 | int:FAM230I | |
| Interaction | SRPK2 interactions | 2.07e-03 | 717 | 38 | 6 | int:SRPK2 | |
| Cytoband | 13q21.1 | 3.78e-13 | 13 | 38 | 5 | 13q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q21 | 4.63e-08 | 117 | 38 | 5 | chr13q21 | |
| Cytoband | Xq13.1 | 7.35e-04 | 48 | 38 | 2 | Xq13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p23 | 6.81e-03 | 149 | 38 | 2 | chr2p23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq13 | 8.29e-03 | 165 | 38 | 2 | chrXq13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q21 | 9.49e-03 | 177 | 38 | 2 | chr15q21 | |
| GeneFamily | Collagens | 1.42e-03 | 46 | 22 | 2 | 490 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 1.03e-05 | 202 | 31 | 5 | gudmap_kidney_P2_CapMes_Crym_k3_500 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_500 | 5.93e-05 | 291 | 31 | 5 | gudmap_kidney_P2_CapMes_Crym_500 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.81e-07 | 200 | 35 | 5 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-06 | 160 | 35 | 4 | 237430af14830b38e58da8a4224036e5c6b71c5b | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.56e-06 | 166 | 35 | 4 | e4f14b2dd8c6199fa27cc3e3beeda681a3b5b889 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.97e-06 | 168 | 35 | 4 | 95dc690c1987b05685d36e6bb20eb79308696e30 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.84e-06 | 172 | 35 | 4 | 1ef243bce63d841c25e4b74d029d1377f84bcc3d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.84e-06 | 172 | 35 | 4 | ab1c81be29f93ca8920c6ab5ab92f497a9256d3f | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.84e-06 | 172 | 35 | 4 | 30916a902c151907745756d14327e24adc34afef | |
| ToppCell | Control-Stromal-Pericyte|Control / Disease state, Lineage and Cell class | 1.03e-05 | 174 | 35 | 4 | 91fc1f1c891f105a91968c22e2de5321c52b439a | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 176 | 35 | 4 | 29cda51a99100ddd2928cadc92da40f001d7e1f4 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 176 | 35 | 4 | 01774a86d7d92f31a056b753f9844f923038003e | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-05 | 177 | 35 | 4 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-05 | 177 | 35 | 4 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 179 | 35 | 4 | d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-05 | 181 | 35 | 4 | 098dbb3e0ff531c9720a233123250c1e39a97d4c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 182 | 35 | 4 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NK|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.23e-05 | 182 | 35 | 4 | fb503f8ecd013f1f2161a5841572b57cfcddb6fa | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 182 | 35 | 4 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.26e-05 | 183 | 35 | 4 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | COPD-Stromal-Pericyte|COPD / Disease state, Lineage and Cell class | 1.28e-05 | 184 | 35 | 4 | a56264a22dfc2d3672b20134ab7c3c7c23da5ae1 | |
| ToppCell | Pericytes-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.28e-05 | 184 | 35 | 4 | 3d2d55d0f22874be21665ab37da710482f77fc36 | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.31e-05 | 185 | 35 | 4 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-MEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.31e-05 | 185 | 35 | 4 | 0595e7ab37eed690f6e3d16a9a4e9a4bce2b89db | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-MEC-MEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.31e-05 | 185 | 35 | 4 | 76304829fcfb5934188933ca20d33bc8c8b0dc91 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-05 | 186 | 35 | 4 | 0b2ce9b8a4382d583240647217ad5e2d3fa555c1 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 1.37e-05 | 187 | 35 | 4 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-05 | 188 | 35 | 4 | 0a5b93c131ce8514e996b0c2f39e0fc98636c122 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.40e-05 | 188 | 35 | 4 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-05 | 190 | 35 | 4 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.46e-05 | 190 | 35 | 4 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.46e-05 | 190 | 35 | 4 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | IPF-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 1.58e-05 | 194 | 35 | 4 | 1a41da29d5adaf766a84eff0003b959e4523f7f1 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 194 | 35 | 4 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.58e-05 | 194 | 35 | 4 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | 15-Trachea-Epithelial-Epithelial|Trachea / Age, Tissue, Lineage and Cell class | 1.61e-05 | 195 | 35 | 4 | 9e9283a397f56732a0a5f2e2527f154d4c2dd56a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.65e-05 | 196 | 35 | 4 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-05 | 198 | 35 | 4 | 52ddc1f1ed4ac4c3bac794c90b8feb03e3c221c4 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.71e-05 | 198 | 35 | 4 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.71e-05 | 198 | 35 | 4 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.71e-05 | 198 | 35 | 4 | 6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.75e-05 | 199 | 35 | 4 | f2ad641f36c577ff7019e88ad6b73ed7e46d8c74 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-05 | 199 | 35 | 4 | 9e32644b93fb1c4946dbe388fd5c357304d14e36 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.75e-05 | 199 | 35 | 4 | 7b1b3b108d817fb3b50a710c3146b30bcf9c2f6b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.78e-05 | 200 | 35 | 4 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.78e-05 | 200 | 35 | 4 | 16a7c398626b6e82b394eb3ef013bda3a788659d | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-4|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.78e-05 | 200 | 35 | 4 | 7642a14855589b0b3f68dbdc9e4d3fc7291854f7 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.78e-05 | 200 | 35 | 4 | 780d47f8eff630020dfae32218de495a7e9dbad6 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.78e-05 | 200 | 35 | 4 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.78e-05 | 200 | 35 | 4 | 28dd127787a57276253548d1f030814b1af64481 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.78e-05 | 200 | 35 | 4 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.78e-05 | 200 | 35 | 4 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.78e-05 | 200 | 35 | 4 | cf883ba5dbe6350b93142d625a52b25ff2a8bb63 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-05 | 200 | 35 | 4 | f9bc22ff17bb1c751e6b05bca3f403836f33459a | |
| ToppCell | distal-2-mesenchymal|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.78e-05 | 200 | 35 | 4 | 65a50f03b0027ccefb51b8f77afa283d4a3b3567 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.78e-05 | 200 | 35 | 4 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-05 | 200 | 35 | 4 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | distal-1-mesenchymal-Pericyte|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.78e-05 | 200 | 35 | 4 | ff205afda57b9267016f0c937445da1b0266af9b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.78e-05 | 200 | 35 | 4 | 07641f476cb1a131c2a50258b88cc13bb38c8379 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.78e-05 | 200 | 35 | 4 | 343fa6ba1f52d816d2e41466f674ff8360aecd81 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-05 | 200 | 35 | 4 | 0a7640db28c708003d5da2d19eb651f6fedfd710 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.78e-05 | 200 | 35 | 4 | 444c72334df421375ae6fc69b0adfd4950d49a43 | |
| ToppCell | distal-2-mesenchymal-Pericyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.78e-05 | 200 | 35 | 4 | 4ee0b2f56c2652435fa78bf6b3c90cea28df74e0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.78e-05 | 200 | 35 | 4 | d0c00cdd52c2e001aec9b935f4e981ba77d0386a | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.78e-05 | 200 | 35 | 4 | 5826c17da67bdaba3a828792279004218d8260c8 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.78e-05 | 200 | 35 | 4 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.58e-04 | 134 | 35 | 3 | b959899c89d3a0363a3cd2309155280e0fe5ba88 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 143 | 35 | 3 | 6df16bf0324661cd9707df69cb39f4b5498d6d49 | |
| ToppCell | Control-Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.99e-04 | 145 | 35 | 3 | fe68582f5a15b9714cb84fa32ac880e13cb69895 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-04 | 146 | 35 | 3 | d33bd571c2adf5f89e6f02e77d094c19edd4729c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.24e-04 | 151 | 35 | 3 | 32d35906f4b2bd46b173e87f2dec972eb5da87b3 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-04 | 157 | 35 | 3 | beab0ac47202266b04543c02cfcdda012375e879 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_3|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.56e-04 | 158 | 35 | 3 | 0559cc032d0b518bb9e55aa3495f5573bd8e87dd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.56e-04 | 158 | 35 | 3 | 4d997efc36fd8946775fe74dd9ac9ccd5ade64ff | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.61e-04 | 159 | 35 | 3 | cb2470b288c13e454a2a80115b0d5613b3f718e6 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.61e-04 | 159 | 35 | 3 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-04 | 164 | 35 | 3 | 1a9b444d2c6abcc83d4355ec5228b27541df2bd0 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.96e-04 | 166 | 35 | 3 | d373f1092e85eeb317a7406032b259f11e6adbe0 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.96e-04 | 166 | 35 | 3 | f453a1d545d59003d98485ac31e85e6cf451817c | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.01e-04 | 167 | 35 | 3 | 805129f887078340b260aa136b0ba19f2bd6ea03 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.01e-04 | 167 | 35 | 3 | 31cf8bf2eb523f6e7e319620648ff37fc09e2601 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.01e-04 | 167 | 35 | 3 | 3acb18428d1d33ad430c2fd031b1a91baee3c01d | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.07e-04 | 168 | 35 | 3 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 169 | 35 | 3 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.12e-04 | 169 | 35 | 3 | 0d96c0b4fd26fbc0bf44ff7bed2936eebcc55b74 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-04 | 170 | 35 | 3 | 60bbd738c12e64e483485586c30057304884f5a6 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.17e-04 | 170 | 35 | 3 | d9ed257d0938442d0bb280e4c4b0c9b657511b46 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-04 | 171 | 35 | 3 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-04 | 171 | 35 | 3 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 3.23e-04 | 171 | 35 | 3 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | Immune_cells-pro-B|Immune_cells / Lineage and Cell class | 3.28e-04 | 172 | 35 | 3 | 096636f2589fa56d15942aac96641c16fd5fa78d | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Basophil|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.28e-04 | 172 | 35 | 3 | 6503e85182eb6e8a40a890e393e9ac5c5350e322 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-04 | 172 | 35 | 3 | 107417cfab7775bc1f80807115047abfb50b7a7e | |
| ToppCell | Control-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 3.28e-04 | 172 | 35 | 3 | 813d4256b05b66ca11b08cc0026459d79f12c0eb | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.28e-04 | 172 | 35 | 3 | 3c0bf7200e582ee730af49dcd86446e112226aca | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.28e-04 | 172 | 35 | 3 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.34e-04 | 173 | 35 | 3 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-04 | 173 | 35 | 3 | ecbf7167d4bec685e3460d826318544946f5f5c2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-04 | 173 | 35 | 3 | b8dc978c52de64afba21ff6cb32e79f07167448e | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-04 | 174 | 35 | 3 | 4cdf2eedc28d88d18241ee390092426fdf849e79 | |
| ToppCell | Immune_cells-pro-B|World / Lineage and Cell class | 3.40e-04 | 174 | 35 | 3 | e173adbf5789dfa20f3cbc668efde5f0992ac219 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-04 | 174 | 35 | 3 | 268be5e7d2a18b866770b7cdb966c3958c7e6534 | |
| Disease | obsolete aging, cognition | 6.02e-12 | 15 | 36 | 5 | EFO_0003925, GO_0007568 | |
| Disease | mosaic loss of chromosome Y measurement | 5.99e-10 | 80 | 36 | 6 | EFO_0007783 | |
| Disease | t-tau:beta-amyloid 1-42 ratio measurement | 1.71e-08 | 66 | 36 | 5 | EFO_0007708 | |
| Disease | Tinnitus, wellbeing measurement | 1.14e-07 | 96 | 36 | 5 | EFO_0007869, HP_0000360 | |
| Disease | telomere length | 2.02e-06 | 313 | 36 | 6 | EFO_0004505 | |
| Disease | Bilateral Wilms Tumor | 5.76e-04 | 29 | 36 | 2 | C2930471 | |
| Disease | Nephroblastoma | 8.88e-04 | 36 | 36 | 2 | C0027708 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LGNPGGPEQQVPTDE | 241 | P48751 | |
| QPLPGGQDSQCGEEP | 181 | O00155 | |
| EKVVAGEVNPPNGPV | 291 | Q5JTC6 | |
| AAKVPNDGQNPGPEE | 1286 | Q9BXF3 | |
| KPDVSNGQPEVTGEP | 241 | P30301 | |
| VPPIPKQDGGEQNGG | 341 | Q6PIW4 | |
| EGPGQESEQPAQPPE | 41 | Q5TC84 | |
| PPPGGKQQGRQCDET | 2131 | P46821 | |
| PAQQPGNEEEKGAPD | 251 | Q76G19 | |
| ENESGGDKPPIDPNN | 181 | P31269 | |
| TGEQRPPPQGETGKE | 1316 | P48681 | |
| GTLDQPPNQEDKPGA | 836 | Q6NV74 | |
| GTVQEGPGPDVAQPE | 146 | P86480 | |
| EPDGPLPGSDNNQEK | 61 | Q96LP2 | |
| GTVQEGPGPDVAQPE | 146 | P86496 | |
| GTVQEGPGPDVAQPE | 146 | P86481 | |
| PEDGTPQPGNSKVEV | 261 | O95996 | |
| GPGAEPEQKEQSTGQ | 976 | Q9Y4L1 | |
| LGQPEPPQEGGSQKS | 606 | P32927 | |
| QIGDNAKGPPTNVEP | 381 | Q5JSL3 | |
| PGSPGQEQAAEGAPE | 76 | P14138 | |
| DPGNPGQDSQERGPK | 2156 | P12111 | |
| GEQGVEGAPAAPVPQ | 856 | Q9Y6C2 | |
| PAVIEKGQQFEGPPG | 381 | P25940 | |
| VPGEPLGDETQGQQP | 171 | Q96AC6 | |
| GDGNQDDGPQQGPPQ | 61 | P02810 | |
| SPVPGQKGEPGETGQ | 106 | A6NHN0 | |
| ENSPKETQEPGPGEA | 856 | A6NGG8 | |
| GQKPEGEPQQDPGTE | 431 | Q5HYW3 | |
| ELEQNSGGKPSPEGP | 471 | Q8TF05 | |
| GTVQEGPGPDVAQPE | 146 | P86479 | |
| GTVQEGPGPDVAQPE | 146 | P86478 | |
| NAEGQTPAIGPDGEP | 591 | P51532 | |
| EPEGQAIEPEGQPIK | 371 | Q0P6D6 | |
| NEIPGKQPPVGGVSD | 376 | Q6S5L8 | |
| PIQGPKGVDEDDPVN | 306 | Q96JI7 | |
| NIQPGDPGPGDQEKQ | 116 | P52736 | |
| GEAQPQAQPETKPEG | 316 | Q9BXA7 | |
| GSPGQEEELPQGQPQ | 171 | Q14202 |